Primary Site >> Liver Cancer
Gene >> CLTC
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: [Hepatocellular carcinoma (CHC) in patients chronically infected with HBV]. PMID: 1668701 |
Ref: Hepatitis C virus 1b is the dominant genotype in HCV-related carcinogenesis: a case-control study. PMID: 8895540 |
Ref: The effectiveness of interferon therapy on occurrence of hepatocellular carcinoma in chronic hepatitis C. PMID: 9683829 Ref: Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. PMID: 9696501 Ref: [Hepatocellular carcinoma: clinical and epidemiological characteristics]. PMID: 9773152 |
Ref: Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study. PMID: 10389289 |
Ref: Why and how to treat chronic hepatitis C. PMID: 10938505 Ref: Patients with chronic hepatitis C--who should not be treated? PMID: 10938508 |
Ref: HCV genotypes and age distribution in patients of Vienna and surrounding areas. PMID: 11163582 Ref: Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. PMID: 11197250 Ref: [Interferon alpha--treatment predictive response factors in group of adults patients with chronic hepatitis C]. PMID: 11993412 |
Ref: Management of viral hepatitis C. PMID: 12000600 Ref: Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study. PMID: 12170085 Ref: Long term follow-up of a group of chronic hepatitis C patients treated with anti-inflammatory drugs following initial interferon therapy. PMID: 12393022 |
Ref: Consensus guidelines for the management of hepatitis C infection. PMID: 25121186 |
Ref: Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma. PMID: 15128351 Ref: Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection. PMID: 15230860 Ref: [Surgical treatment of hepatocellular carcinoma--indications, limitations, realities]. PMID: 15279442 Ref: The Bcl-2 and TGF-beta1 levels in patients with chronic hepatitis C, liver cirrhosis and hepatocellular carcinoma. PMID: 15724390 Ref: Clinical Profiles of Chronic Hepatitis C in a Major County Medical Center Outpatient Setting in United States. PMID: 15912201 |
Ref: Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy. PMID: 15853990 Ref: Accumulation of 8-nitroguanine in the liver of patients with chronic hepatitis C. PMID: 16023246 Ref: Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments. PMID: 16108772 Ref: Alterations of soluble transferrin receptor level in children with chronic hepatitis C during treatment with recombinant interferon-alpha and ribavirin. PMID: 16165397 Ref: [The clinical consequences of changes occurring in HCV population during the first weeks of chronic hepatitis C treatment with interferon and ribavirin]. PMID: 16190569 Ref: [Detection of hepatitis C virus RNA in the liver biopsy specimens from patients with chronic hepatitis C and hepatocellular carcinoma by means of in situ RT-PCR]. PMID: 16408622 |
Ref: Prognostic impact of cholangiocellular and sarcomatous components in combined hepatocellular and cholangiocarcinoma. PMID: 16613323 Ref: Lifestyle changes and beliefs regarding disease severity in patients with chronic hepatitis C. PMID: 16792542 Ref: Increased hepatic expression of insulin-like growth factor-I receptor in chronic hepatitis C. PMID: 16804965 Ref: Long-term results of liver transplant in patients with chronic viral hepatitis-related liver disease in Singapore. PMID: 16810429 Ref: Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma. PMID: 16856963 Ref: Treatment options for chronic hepatitis B and C infection in children. PMID: 17009938 Ref: A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy. PMID: 17058238 Ref: Optimizing treatment outcomes in chronic hepatitis C: management of non-response. PMID: 17302365 Ref: A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan. PMID: 17302368 |
Ref: Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy. PMID: 17444854 Ref: The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance. PMID: 17530668 Ref: Clinical and ultrasonographic features of the canine hepatocellular carcinoma (CHC). PMID: 17682898 Ref: Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C. PMID: 17940836 Ref: Gene systems network inferred from expression profiles in hepatocellular carcinogenesis by graphical Gaussian model. PMID: 18060013 Ref: Long-term effects of interferon-based therapy for chronic hepatitis C. PMID: 18087178 Ref: Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma. PMID: 18092051 |
Ref: Review article: nonalcoholic fatty liver disease and hepatitis C virus--partners in crime. PMID: 18315584 Ref: Treatment regimens for patients with chronic hepatitis C. PMID: 18319692 Ref: Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma. PMID: 18379139 Ref: Identification of novel immunohistochemical tumor markers for primary hepatocellular carcinoma; clathrin heavy chain and formiminotransferase cyclodeaminase. PMID: 18571811 Ref: Circulating and hepatic Fas expression in HCV-induced chronic liver disease and hepatocellular carcinoma. PMID: 18679533 Ref: An analysis of risk factors for developing Hepatocellular carcinoma in a group of Hepatitis C patients with stage 3 fibrosis following interferon therapy. PMID: 19259418 |
Ref: When to treat and the benefits of treating hepatitis C in patients with haemophilia. PMID: 18976253 Ref: Characterization of hepatocellular carcinoma developed after achieving sustained virological response to interferon therapy for hepatitis C. PMID: 18985618 Ref: Serum alpha-fetoprotein levels during and after interferon therapy and the development of hepatocellular carcinoma in patients with chronic hepatitis C. PMID: 19093203 Ref: Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. PMID: 19140227 Ref: Retreatment of chronic hepatitis C: who and how? PMID: 19207966 Ref: Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer. PMID: 19212669 Ref: Hepatogenous diabetes. Current views of an ancient problem. PMID: 19221528 Ref: Use of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C. PMID: 19221530 Ref: Clinical implications of alpha-fetoprotein in chronic hepatitis C. PMID: 19293036 Ref: [Clinical - Epidemiological characteristics of the Hepatocellular Carcinoma and treatment in the departament of digestive system diseases of the National Hospital "Eduardo Rebagliatti Martins" (HNERM) - ESSALUD]. PMID: 19424404 Ref: Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. PMID: 19436294 Ref: Managing pediatric hepatitis C: current and emerging treatment options. PMID: 19707281 Ref: Hepatitis C: Should antiviral therapy be offered to elderly patients? PMID: 19713980 Ref: Reduced serum hepcidin levels in patients with chronic hepatitis C. PMID: 19729219 Ref: Molecular mechanisms of insulin resistance in chronic hepatitis C. PMID: 19764085 Ref: Current status of liver disease in Korea: hepatitis C. PMID: 20037276 Ref: [Chronic hepatitis C: etiology, pathogenesis, treatment]. PMID: 20143559 Ref: Hepcidin mRNA level as a parameter of disease progression in chronic hepatitis C and hepatocellular carcinoma. PMID: 21415870 |
Ref: Hepatitis C and diabetes: one treatment for two diseases? PMID: 20040049 Ref: The importance of steatosis in chronic hepatitis C infection and its management: A review. PMID: 20394672 Ref: Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma. PMID: 20395200 Ref: [Surveillance of cirrhosis for hepatocellular carcinoma--clinical validation of new serological biomarkers for improved diagnosis]. PMID: 20509274 Ref: Telaprevir: a new hope in the treatment of chronic hepatitis C? PMID: 20652658 Ref: Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. PMID: 20675691 Ref: [Percutaneous and intra-arterial treatment of hepatocellular carcinoma]. PMID: 20864139 Ref: Hydroxyurea suppresses HCV replication in humans: a Phase I trial of oral hydroxyurea in chronic hepatitis C patients. PMID: 21149925 Ref: Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinoma. PMID: 21160954 Ref: Prognostic value of TNF a mRNA and VEGF mRNA expression in patients with chronic hepatitis C genotype-4, with and without cirrhosis and hepatocellular carcinoma to predict disease outcome. PMID: 21246958 Ref: [Chronic hepatitis and occult HCV infection]. PMID: 21473042 Ref: Interferon-alpha induced and ribavirin induced thyroid dysfunction in patients with chronic hepatitis C. PMID: 22312386 |
Ref: The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - a multicenter prospective trial. PMID: 21056500 Ref: Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients. PMID: 21170963 Ref: Long-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirin. PMID: 21274379 Ref: Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C. PMID: 21319195 Ref: IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C. PMID: 21443535 Ref: Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. PMID: 21499248 Ref: Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma. PMID: 21520170 Ref: Clathrin heavy chain (CHC) staining for the diagnosis of small hepatocellular carcinoma. PMID: 21677345 Ref: A cohort study to investigate hepatocellular carcinoma risk in hepatitis C patients. PMID: 21830414 Ref: An overview of emerging therapies for the treatment of chronic hepatitis C. PMID: 21867934 Ref: Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PMID: 21886843 Ref: Mechanisms involved in the development of chronic hepatitis C as potential targets of antiviral therapy. PMID: 21902631 Ref: Predicting cirrhosis and clinical outcomes in patients with advanced chronic hepatitis C with a panel of genetic markers (CRS7). PMID: 21946897 Ref: Genetic variants of interferon-stimulated genes and IL-28B as host prognostic factors of response to combination treatment for chronic hepatitis C. PMID: 21993426 Ref: Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma. PMID: 22044490 Ref: Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma. PMID: 22066022 Ref: Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin. PMID: 22102384 Ref: Tailor-made therapy for viral hepatitis: recent advances. PMID: 22156478 Ref: Pegaferon in hepatitis C: Results of a Multicenter Study. PMID: 25197541 Ref: Intrahepatic cholangiocellular carcinoma and hepatocellular carcinoma developed after a 6-year sustained virological response to interferon therapy for chronic hepatitis C. PMID: 26189349 Ref: Helicobacter Pylori DNA in Liver Tissues From Chronic Hepatitis C Egyptian Patients. PMID: 27957026 |
Ref: Identification of osteopontin as a novel marker for early hepatocellular carcinoma. PMID: 21953299 Ref: Genomic risk of hepatitis C-related hepatocellular carcinoma. PMID: 21963516 Ref: Increased serum activin-A differentiates alcoholic from cirrhosis of other aetiologies. PMID: 22304651 Ref: Role of fibrogenic markers in chronic hepatitis C and associated hepatocellular carcinoma. PMID: 22318548 Ref: Copy number aberrations in combined hepatocellular carcinoma and cholangiocarcinoma. PMID: 22366251 Ref: Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma. PMID: 22407776 Ref: Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma. PMID: 22431178 Ref: Do hepatitis B virus and hepatitis C virus co-infections increase hepatocellular carcinoma occurrence through synergistically modulating lipogenic gene expression? PMID: 22487144 Ref: Rapid normalization of alanine aminotransferase predicts viral response during combined peginterferon and ribavirin treatment in chronic hepatitis C patients. PMID: 22511902 Ref: A critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis C or B: a novel approach by using meta-regression. PMID: 22555181 Ref: Association of IL28B SNP With Progression of Egyptian HCV Genotype 4 Patients to End Stage Liver Disease. PMID: 22690235 Ref: Association between metabolic abnormalities and hepatitis C-related hepatocellular carcinoma. PMID: 22700630 Ref: Immigrant patients with chronic hepatitis C and advanced fibrosis have a higher risk of hepatocellular carcinoma. PMID: 22762142 Ref: Resource use and cost of hepatitis C-related care. PMID: 22836284 Ref: The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls. PMID: 22898488 Ref: A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy. PMID: 22899800 Ref: Hepatitis C virus infection and nonalcoholic steatohepatitis. PMID: 22933860 Ref: Clinical significance of elevated alpha-foetoprotein (AFP) in patients with chronic hepatitis C without hepatocellular carcinoma in upper EGYPT. PMID: 22980591 Ref: Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma. PMID: 23082062 Ref: Chronic hepatitis C in saudi arabia: three years local experience in a university hospital. PMID: 23087760 Ref: The kinetics of virological and biochemical responses in the treatment of chronic hepatitis C by dual antiviral therapy. PMID: 23097965 Ref: Nutrition therapy for liver diseases based on the status of nutritional intake. PMID: 23197979 Ref: Gender differences in the livers of patients with hepatocellular carcinoma and chronic hepatitis C infection. PMID: 23258093 Ref: Risk of hepatocellular carcinoma development in cases of hepatitis C treated by long-term, low-dose PEG-IFNalpha-2a. PMID: 23258095 Ref: The role of fas/fas ligand system in the pathogenesis of liver cirrhosis and hepatocellular carcinoma. PMID: 23300494 Ref: Alterations of insulin-like growth factor I (IGF-I) and estradiol serum levels in chronic hepatitis C. PMID: 23788886 Ref: Human Interferon Regulatory Factor 2 Gene Expression is Induced in Chronic Hepatitis C Virus Infection-A Possible Mode of Viral Persistence. PMID: 25755403 Ref: A pharmacological profile of ribavirin and monitoring of its plasma concentration in chronic hepatitis C infection. PMID: 25755405 Ref: IL28B, HCV core mutations, and hepatocellular carcinoma: does host genetic make-up shape viral evolution in response to immunity? PMID: 26201341 |
Ref: Innate immunity and HCV. PMID: 23063572 Ref: Glucose abnormalities in hepatitis C virus infection. PMID: 23347806 Ref: Hepatitis C in patients with beta-thalassemia major. A single-centre experience. PMID: 23412560 Ref: Association of interleukin-28B genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis C. PMID: 23426277 Ref: A prospective study of long-term outcomes in female patients with nonalcoholic steatohepatitis using age- and body mass index-matched cohorts. PMID: 23439508 Ref: Long-term outcome of chronic hepatitis C after sustained virological response to interferon-based therapy. PMID: 23461575 Ref: Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia-Pacific region. PMID: 23463401 Ref: Genetic variants of heat shock protein A1L2437 and A1B1267 as possible risk factors for hepatocellular carcinoma in India. PMID: 23490384 Ref: Comparison of hepatocellular carcinoma (HCC), cholangiocarcinoma (CC), and combined HCC-CC (CHC) with each other based on microarray dataset. PMID: 23532688 Ref: Systematic review: Asian patients with chronic hepatitis C infection. PMID: 23557103 Ref: Cancer biomarker profiling in patients with chronic hepatitis C virus, liver cirrhosis and hepatocellular carcinoma. PMID: 23564159 Ref: alpha-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C. PMID: 23564522 Ref: Sustained virological response: a milestone in the treatment of chronic hepatitis C. PMID: 23687416 Ref: Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations. PMID: 23768703 Ref: The insulin-like growth factor-1 and expression of its binding protein3 in chronic hepatitis C and hepatocellular carcinoma. PMID: 23784592 Ref: Hepatitis C--an update. PMID: 23826595 Ref: Epidermal growth factor, its receptor and transforming growth factor-beta1 in the diagnosis of HCV-induced hepatocellular carcinoma. PMID: 23912699 Ref: Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma. PMID: 24086533 Ref: A Possible Role for TNF-alpha in Coordinating Inflammation and Angiogenesis in Chronic Liver Disease and Hepatocellular Carcinoma. PMID: 24147158 Ref: Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients. PMID: 24186850 Ref: Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment. PMID: 24206736 Ref: Reactive oxygen species induce epigenetic instability through the formation of 8-hydroxydeoxyguanosine in human hepatocarcinogenesis. PMID: 24281021 Ref: Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C. PMID: 24409059 Ref: Deveopment of hepatocellular carcinoma in a non-cirrhotic, long-term responder to antiviral therapy, chronic hepatitis C patient: what kind of surveillance? PMID: 24714548 |
Ref: IL28B minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. PMID: 23689989 Ref: Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin. PMID: 23829453 Ref: Chronic hepatitis C as a risk factor for colorectal adenoma. PMID: 23982424 Ref: Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data. PMID: 24114809 Ref: Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon-based anti-viral therapy. PMID: 24117602 Ref: Impact of PNPLA3 polymorphisms on the development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. PMID: 24125181 Ref: Low hepcidin triggers hepatic iron accumulation in patients with hepatitis C. PMID: 24286977 Ref: Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma. PMID: 24407728 Ref: Integrins alphavbeta6, alpha6beta4 and alpha3beta1 are down-regulated in cholangiolocellular carcinoma but not cholangiocarcinoma. PMID: 24552196 Ref: Image analysis of liver biopsy samples measures fibrosis and predicts clinical outcome. PMID: 24607623 Ref: Complementary and alternative medications in hepatitis C infection. PMID: 24653790 Ref: Individualization of chronic hepatitis C treatment according to the host characteristics. PMID: 24659876 Ref: Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C. PMID: 24841704 Ref: Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: a nationwide cohort study. PMID: 24919583 Ref: Hepatic steatosis: prevalence and host/viral risk factors in Iranian patients with chronic hepatitis B infection. PMID: 24935567 Ref: Hepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection. PMID: 24944463 Ref: Comparison of quasispecies diversity of HCV between chronic hepatitis c and hepatocellular carcinoma by Ultradeep pyrosequencing. PMID: 24999482 Ref: Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C. PMID: 25171251 Ref: [Natural clearance of hepatitis C virus in 96 patients with infection acquired by blood transfusion from a single donor in Guizhou]. PMID: 25173221 Ref: [Chronic hepatitis C presenting with a diagnosis of hepatocellular carcinoma]. PMID: 25293410 Ref: Hepatitis C virus infection and type 1 and type 2 diabetes mellitus. PMID: 25317237 Ref: [Increased risk of hepatocellular carcinoma in patients with chronic hepatitis C]. PMID: 25331666 Ref: Hepatitis C virus recurrence after liver transplantation: how to treat and when. PMID: 25420834 Ref: PMID: 25473722 Ref: Cirrhotic patients are still at risk of developing hepatocellular carcinoma despite Interferon-induced sustained virological response. PMID: 25535185 Ref: PMID: 27170975 |
Ref: Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma. PMID: 24712771 Ref: Cardiovascular disease and hepatitis C virus infection: an irrelevant statement or a hot relationship? PMID: 24926806 Ref: Epithelial cell adhesion molecule-positive human hepatic neoplastic cells: development of combined hepatocellular-cholangiocarcinoma in mice. PMID: 25087473 Ref: Impact of serum levels of interleukin-6 and adiponectin on all-cause, liver-related, and liver-unrelated mortality in chronic hepatitis C patients. PMID: 25168107 Ref: Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virological response by pegylated interferon and ribavirin. PMID: 25236421 Ref: Epidemiology, disease burden and outcomes of cirrhosis in a large secondary care hospital in South Auckland, New Zealand. PMID: 25371019 Ref: Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma. PMID: 25391771 Ref: Identification of cancer stem cell subpopulations of CD34(+) PLC/PRF/5 that result in three types of human liver carcinomas. PMID: 25519836 Ref: Current and future HCV therapy: do we still need other anti-HCV drugs? PMID: 25529081 Ref: Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations. PMID: 25574103 Ref: Chronic hepatitis C virus infection triggers spontaneous differential expression of biosignatures associated with T cell exhaustion and apoptosis signaling in peripheral blood mononucleocytes. PMID: 25577277 Ref: ABT-450: a novel agent for the treatment of CHC genotype 1: focus on treatment-experienced patients. PMID: 25582226 Ref: Long-term follow-up of chronic hepatitis C patients treated with interferon-alpha: risk of cirrhosis and hepatocellular carcinoma in a single center over 10 years. PMID: 25592614 Ref: PNPLA3 I148M associations with liver carcinogenesis in Japanese chronic hepatitis C patients. PMID: 25713769 Ref: Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients. PMID: 25735368 Ref: Plasma lipidomic fingerprinting to distinguish among hepatitis C-related hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis C using MALDI-TOF mass spectrometry: a pilot study. PMID: 25822433 Ref: Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy. PMID: 25848483 Ref: Potential Role of Hepatitis C Virus Alternate Reading Frame Protein in Negative Regulation of T-Bet Gene Expression. PMID: 25894282 Ref: Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma. PMID: 25963067 Ref: FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53. PMID: 25995247 Ref: The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patients. PMID: 26094738 Ref: Disease burden of chronic hepatitis C among immigrants in Canada. PMID: 26110922 Ref: Interleukin- 28B: a prognostic marker in interferon based therapy of chronic HCV patients of the Pakistan with variable treatment response. PMID: 26177560 Ref: Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study. PMID: 26211742 Ref: The Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 Diabetes. PMID: 26226632 Ref: Impact of epidermal growth factor receptor and transforming growth factor-alpha on hepatitis C virus-induced hepatocarcinogenesis. PMID: 26279457 Ref: Retraction Note to: Comparison of hepatocellular carcinoma (HCC), cholangiocarcinoma (CC), and combined HCC-CC (CHC) with each other based on microarray dataset. PMID: 26281985 Ref: Oral delivery of shRNA based on amino acid modified chitosan for improved antitumor efficacy. PMID: 26310108 Ref: The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment. PMID: 26327920 Ref: IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma. PMID: 26367076 Ref: Alpha-fetoprotein before and after pegylated interferon therapy for predicting hepatocellular carcinoma development. PMID: 26380048 Ref: Role of occult hepatitis B virus infection in chronic hepatitis C. PMID: 26576082 Ref: Effect of Treatment for CHC on Liver Disease Progression and Hepatocellular Carcinoma Development in African Americans. PMID: 26623262 Ref: Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis Programs. PMID: 26646011 Ref: Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma. PMID: 26816590 |
Ref: Glutathione peroxidase 4 is reversibly induced by HCV to control lipid peroxidation and to increase virion infectivity. PMID: 25516417 Ref: Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C. PMID: 26290259 Ref: Morphophenotypic changes in human multistep hepatocarcinogenesis with translational implications. PMID: 26343958 Ref: Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response. PMID: 26347515 Ref: Chronic hepatitis C: Burden of disease and cost associated with hospitalisations in France in 2012 (The HEPC-LONE study). PMID: 26546175 Ref: Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis. PMID: 26634931 Ref: Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study. PMID: 26741637 Ref: Virologic responses and tolerance of peginterferon alfa plus ribavirin treatment for patients with chronic hepatitis C virus infection in different age categories. PMID: 26755232 Ref: Metabolic alterations and hepatitis C: From bench to bedside. PMID: 26819514 Ref: Serum models accurately predict liver-related clinical outcomes in chronic hepatitis C. PMID: 26945918 Ref: The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type. PMID: 26969740 Ref: Epidemiology and outcomes of hepatitis C infection in elderly US Veterans. PMID: 27040447 Ref: Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US. PMID: 27063573 Ref: Staufen1 promotes HCV replication by inhibiting protein kinase R and transporting viral RNA to the site of translation and replication in the cells. PMID: 27106056 Ref: Incidental Intra-Hepatic Cholangiocarcinoma and Hepatocholangiocarcinoma in Liver Transplantation: A Single-Center Experience. PMID: 27109957 Ref: Evaluation of Circulatory RNA-Based Biomarker Panel in Hepatocellular Carcinoma. PMID: 27113935 Ref: Treatment Response and Long-Term Outcome of Peginterferon alpha and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C. PMID: 27114417 Ref: Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index. PMID: 27114418 Ref: Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region. PMID: 27114433 Ref: Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model. PMID: 27122667 Ref: HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2. PMID: 27183918 Ref: Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma. PMID: 27215316 Ref: Improving Healthcare Systems to Reduce Healthcare Disparities in Viral Hepatitis. PMID: 27234269 Ref: Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy. PMID: 27254286 Ref: Clinical Model for Predicting Hepatocellular Carcinomas in Patients with Post-Sustained Virologic Responses of Chronic Hepatitis C: A Case Control Study. PMID: 27257023 Ref: Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. PMID: 27271989 Ref: Is exposure to Agent Orange a risk factor for hepatocellular cancer?-A single-center retrospective study in the U.S. veteran population. PMID: 27284476 Ref: Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy. PMID: 27399135 Ref: Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy. PMID: 27435935 Ref: Claudins-4 and -7 might be valuable markers to distinguish hepatocellular carcinoma from cholangiocarcinoma. PMID: 27444172 Ref: Estimation of direct medical cost related to the management of chronic hepatitis C and its complications in South Korea. PMID: 27472670 Ref: Inhibition of emotional needs and emotional wellbeing predict disease progression of chronic hepatitis C patients: an 8-year prospective study. PMID: 27478498 Ref: Quantitative proteome analysis reveals the correlation between endocytosis-associated proteins and hepatocellular carcinoma dedifferentiation. PMID: 27519163 Ref: Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients. PMID: 27574588 Ref: Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis. PMID: 27605882 Ref: Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent Era. PMID: 27631382 Ref: Host - hepatitis C viral interactions: The role of genetics. PMID: 27641986 Ref: The effect of standard therapy on mean platelet volume in patients with chronic hepatitis C. PMID: 27713783 Ref: Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence. PMID: 27783223 Ref: Prognostic Value of Transient Elastography in Human Immunodeficiency Virus-Infected Patients With Chronic Hepatitis C. PMID: 27833930 Ref: Association between ABO blood group and HCV-related hepatocellular carcinoma risk in China. PMID: 27930575 Ref: [Assessment of awareness about the epidemiology, outcomes, and therapy of chronic hepatitis B and C in adolescents and adults]. PMID: 28005030 Ref: PNPLA3 polymorphism increases risk for and severity of chronic hepatitis C liver disease. PMID: 28050240 Ref: Hepatitis C in Canada and the importance of risk-based screening. PMID: 29770005 |
Ref: Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden. PMID: 27598393 Ref: Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of Treatment. PMID: 27733478 Ref: The impact of hepatitis C virus outside the liver: Evidence from Asia. PMID: 27748564 Ref: Genome-wide association study: new genetic insights into HBV/HCV-related hepatocellular carcinoma genomes. PMID: 27797287 Ref: Intrahepatic angiopoietin-2 correlates with chronic hepatitis C progression and is induced in hepatitis C virus replicon systems. PMID: 28027429 Ref: Clinical features of hepatitis B and C virus infections, with high alpha-fetoprotein levels but not hepatocellular carcinoma. PMID: 28079817 Ref: Increased Red Cell Distribution Width is Strong Inflammatory Marker of Liver Diseases in a Guangxi Population. PMID: 28182351 Ref: The benefit of statins in chronic hepatitis C patients: a systematic review and meta-analysis. PMID: 28240613 Ref: Long-term outcome of chronic hepatitis C virus infection in a real-world setting: The German LOTOS study. PMID: 28247572 Ref: Liver transplantation and combined hepatocellular-cholangiocarcinoma: Feasibility and outcomes. PMID: 28258929 Ref: MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma. PMID: 28261837 Ref: Cost-effectiveness analysis of ledipasvir/sofosbuvir in patients with chronic hepatitis C: Treatment of patients with absence or mild fibrosis compared to patients with advanced fibrosis. PMID: 28273410 Ref: Diabetes mellitus increases the risk of hepatocellular carcinoma in treatment-naive chronic hepatitis C patients in China. PMID: 28353605 Ref: Genetic Polymorphism of Epidermal Growth Factor rs4444903 Influences Susceptibility to HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma in a Chinese Han Population. PMID: 28397482 Ref: Clinical significance of SNP (rs2596542) in histocompatibility complex class I-related gene A promoter region among hepatitis C virus related hepatocellular carcinoma cases. PMID: 28417047 Ref: Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon and ribavirin antiviral therapy: clinical and fibrosis impact of treatment response. PMID: 28445251 Ref: Higher risk of hepatocellular carcinoma in chronic hepatitis B vs chronic hepatitis C after achievement of virologic response. PMID: 28499070 Ref: The Role of Direct-acting Antivirals in the Treatment of Children with Chronic Hepatitis C. PMID: 28507928 Ref: Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C. PMID: 28539815 Ref: [Analysis of related factors for primary hepatic carcinoma caused by chronic hepatitis B and hepatitis C]. PMID: 28592101 Ref: Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C. PMID: 28627363 Ref: Noninvasive serum models to predict significant liver related events in chronic hepatitis C. PMID: 28634687 Ref: [Treatment of advanced hepatocellular carcinoma : Novel agents and role of local therapy]. PMID: 28636293 Ref: Detection of MicroRNA in Hepatic Cirrhosis and Hepatocellular Carcinoma in Hepatitis C Genotype-4 in Egyptian Patients. PMID: 28642869 Ref: Eradication of hepatitis C virus profoundly prolongs survival in hepatocellular carcinoma patients receiving transarterial chemoembolization. PMID: 28643457 Ref: The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas. PMID: 28645247 Ref: Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis C. PMID: 28704535 Ref: Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients. PMID: 28705056 Ref: [Regional differences in hospitalisations for complications of chronic hepatitis C in 2012]. PMID: 28737341 Ref: Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome. PMID: 28740596 Ref: Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response. PMID: 28766727 Ref: Combined Hepatocellular Cholangiocarcinoma (Biphenotypic) Tumors: Potential Role of Contrast-Enhanced Ultrasound in Diagnosis. PMID: 28777653 Ref: Healthcare Costs for Chronic Hepatitis C in South Korea from 2009 to 2013: An Analysis of the National Health Insurance Claims' Data. PMID: 28798283 Ref: Prevalence and Identification of Serum Markers Associated with Vertical Transmission of Hepatitis B in Pregnant Women in Yaounde, Cameroon. PMID: 28798895 Ref: Imaging Features on Contrast-Enhanced Ultrasound and Clinical Characteristics of Hepatitis B Virus-Related Combined Hepatocellular-Cholangiocarcinoma: Comparison with Hepatitis B Virus-Related Hepatocellular Carcinoma. PMID: 28847498 Ref: Comparative Analysis for Glycopatterns and Complex-Type N-Glycans of Glycoprotein in Sera from Chronic Hepatitis B- and C-Infected Patients. PMID: 28871230 Ref: Current status of and strategies for hepatitis C control in South Korea. PMID: 28942625 Ref: Potential Diagnostic and Prognostic Value of Lymphocytic Mitochondrial DNA Deletion in Relation to Folic Acid Status in HCV-Related Hepatocellular Carcinoma PMID: 28952275 Ref: Unique Characteristics Associated with Sustained Liver Damage in Chronic Hepatitis C Patients Treated with Direct Acting Antivirals. PMID: 29040988 Ref: Assessing risk of fibrosis progression and liver-related clinical outcomes among patients with both early stage and advanced chronic hepatitis C. PMID: 29108017 Ref: Liver-related morbidity and mortality in patients with chronic hepatitis C and cirrhosis with and without sustained virologic response. PMID: 29123424 Ref: Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. PMID: 29131160 Ref: Value and innovation of direct-acting antivirals: long-term health outcomes of the strategic plan for the management of hepatitis C in Spain. PMID: 29152988 Ref: Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy. PMID: 29254684 Ref: [Hepatitis C can be cured: will hepatitis B become next?] PMID: 29260740 Ref: Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma. PMID: 29270746 Ref: Epidemiology of Chronic Hepatitis C Infections at a Tertiary Care Centre in Oman. PMID: 29372081 Ref: Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma. PMID: 30258925 |
Ref: Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma. PMID: 29052791 Ref: Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal study. PMID: 29089161 Ref: Imaging features of combined hepatocellular-cholangiocarcinoma on contrast-enhanced ultrasound: correlation with clinicopathological findings. PMID: 29122222 Ref: Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment. PMID: 29136329 Ref: The association between steatosis and diabetes with hepatocellular carcinoma in non-genotype 3 chronic hepatitis C patients. PMID: 29164767 Ref: Host genetic variations associated with disease progression in chronic hepatitis C virus infection. PMID: 29235266 Ref: Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers. PMID: 29278878 Ref: Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature. PMID: 29322398 Ref: Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients. PMID: 29333940 Ref: Ghrelin gene polymorphism as a genetic biomarker for prediction of therapy induced clearance in Egyptian chronic HCV patients. PMID: 29374597 Ref: Clinical Evaluation of Hepatocarcinogenesis and Outcome Using a Novel Glycobiomarker Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA(+)-M2BP) in Chronic Hepatitis C with Advanced Fibrosis. PMID: 29491234 Ref: MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection. PMID: 29534065 Ref: Rate of hepatocellular carcinoma surveillance remains low for a large, real-life cohort of patients with hepatitis C cirrhosis. PMID: 29607053 Ref: The role of IDO, IL-10, and TGF-beta in the HCV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. PMID: 29611873 Ref: Gut Dysbiosis Associated With Hepatitis C Virus Infection. PMID: 29718124 Ref: Higher risk of hepatocellular carcinoma in Hispanic patients with hepatitis C cirrhosis and metabolic risk factors. PMID: 29740031 Ref: Simple score to predict risk of hepatocellular carcinoma in chronic hepatitis C patients with advanced fibrosis after pegylated interferon and ribavirin therapy. PMID: 29750037 Ref: Phenotypic and molecular changes in nodule-in-nodule hepatocellular carcinoma with pathogenetic implications. PMID: 29791027 Ref: Late development of hepatocellular carcinoma after viral clearance in patients with chronic hepatitis C: A need for continual surveillance. PMID: 29889353 Ref: Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan. PMID: 29893701 Ref: Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates. PMID: 29908364 Ref: Significance of pSmad2/3 and Smad4 in hepatitis C virus-related liver fibrosis and hepatocellular carcinoma. PMID: 29924446 Ref: Polymorphisms of base-excision repair genes and the hepatocarcinogenesis. PMID: 29935355 Ref: Liver Disease in Singapore. PMID: 29963466 Ref: Real-world effectiveness of sofosbuvir plus ribavirin for chronic hepatitis C genotype 2 in Asia: a systematic review and meta-analysis. PMID: 30002863 Ref: IL-1alpha correlates with severity of hepatitis C virus-related liver diseases. PMID: 30022847 Ref: Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients. PMID: 30076015 Ref: Clinical utility of ledipasvir/sofosbuvir in the treatment of adolescents and children with hepatitis C. PMID: 30104913 Ref: Negative impact of hepatitis B surface seroclearance on prognosis of hepatitis B-related primary liver cancer. PMID: 30148147 Ref: Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients. PMID: 30172885 Ref: Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinoma. PMID: 30179227 Ref: Effects of antiviral treatment on the risk of hepatocellular cancer in patients with chronic viral hepatitis. PMID: 30179906 Ref: An intronic single nucleotide polymorphism in the MUTYH gene is associated with increased risk for HCV-induced hepatocellular carcinoma. PMID: 30218772 Ref: CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C. PMID: 30288478 Ref: TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free therapy. PMID: 30382363 |